Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Administration, Oral"" wg kryterium: Temat


Tytuł:
The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis-a nationwide cohort study.
Autorzy:
Tsai CT; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei, Taiwan.; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Chan YH; The Cardiovascular Department, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.; College of Medicine, Chang Gung University, Taoyuan, Taiwan.; Microscopy Core Laboratory, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.
Liao JN; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei, Taiwan.; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Chen TJ; Department of Family Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Lip GYH; Liverpool Centre for Cardiovascular Science, University of Liverpool & Liverpool Heart and Chest Hospital, Liverpool, UK.; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Chen SA; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Cardiovascular Center, Taichung Veterans General Hospital, Taichung, Taiwan.
Chao TF; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei, Taiwan. .; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2024 Mar 13; Vol. 22 (1), pp. 113. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:
Journal Article
MeSH Terms:
Stroke*/complications
Atrial Fibrillation*/complications
Brain Ischemia*/drug therapy
Ischemic Stroke*/drug therapy
Humans ; Warfarin/therapeutic use ; Anticoagulants/therapeutic use ; Fibrinolytic Agents/therapeutic use ; Cohort Studies ; Constriction, Pathologic/chemically induced ; Constriction, Pathologic/complications ; Constriction, Pathologic/drug therapy ; Hemorrhage/chemically induced ; Intracranial Hemorrhages/chemically induced ; Intracranial Hemorrhages/complications ; Intracranial Hemorrhages/drug therapy ; Arteries ; Administration, Oral
Czasopismo naukowe
Tytuł:
Recombinant L. lactis vaccine LL-plSAM-WAE targeting four virulence factors provides mucosal immunity against H. pylori infection.
Autorzy:
Zhang F; College of First Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China.; College of Laboratory Medicine , Ningxia Medical University, Yinchuan, 750004, China.
Ni L; College of Pharmacy, Ningxia Medical University, Yinchuan, 750004, China.
Zhang Z; Department of Geriatrics and Special Needs Medicine, General Hospital of Ningxia Medical University, Yinchuan, 750004, China.
Luo X; Key Laboratory of Industrial Fermentation Microbiology of the Ministry of Education, College of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, China.
Wang X; Key Laboratory of Radiation Oncology of Taizhou, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, 317000, China.
Zhou W; College of First Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China.
Chen J; College of First Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China.
Liu J; College of Laboratory Medicine , Ningxia Medical University, Yinchuan, 750004, China.
Qu Y; College of Laboratory Medicine , Ningxia Medical University, Yinchuan, 750004, China. .
Liu K; College of Pharmacy, Ningxia Medical University, Yinchuan, 750004, China. .; Ningxia Key Laboratory of Cerebrocranial Diseases, Ningxia Medical University, Yinchuan, 750004, China. .
Guo L; College of First Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China. .; College of Laboratory Medicine , Ningxia Medical University, Yinchuan, 750004, China. .; Ningxia Key Laboratory of Cerebrocranial Diseases, Ningxia Medical University, Yinchuan, 750004, China. .; Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, General Hospital of Ningxia Medical University, Yinchuan, 750004, China. .
Pokaż więcej
Źródło:
Microbial cell factories [Microb Cell Fact] 2024 Feb 24; Vol. 23 (1), pp. 61. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Helicobacter pylori*
Animals ; Mice ; Immunity, Mucosal ; Virulence Factors ; Bacterial Vaccines ; Urease ; Vaccines, Synthetic ; Mice, Inbred BALB C ; Administration, Oral
Czasopismo naukowe
Tytuł:
Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19.
Autorzy:
Valdez-Cruz NA; Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Cd. Universitaria, Coyoacán, Ciudad de Mexico, México. AP. 70228, CP. 04510, México, D.F, Mexico. .; Centro de Nanociencias y Nanotecnología, Universidad Nacional Autónoma de México, Km 107 Carretera, 22860, Tijuana-Ensenada, Baja California, Mexico. .
Rosiles-Becerril D; Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Cd. Universitaria, Coyoacán, Ciudad de Mexico, México. AP. 70228, CP. 04510, México, D.F, Mexico.
Martínez-Olivares CE; Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Cd. Universitaria, Coyoacán, Ciudad de Mexico, México. AP. 70228, CP. 04510, México, D.F, Mexico.
García-Hernández E; Instituto de Química, Universidad Nacional Autónoma de México, Ciudad Universitaria, 04510, Ciudad de México, Mexico.
Cobos-Marín L; Departamento de Microbiología e Inmunología, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, Ciudad Universitaria, 04510, Ciudad de México, Mexico.
Garzón D; Unidad de Modelos Biológicos, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Cd. Universitaria, Coyoacán, Ciudad de Mexico, Mexico. AP. 70228, CP. 04510, México, D.F, Mexico.
López-Salas FE; Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Cd. Universitaria, Coyoacán, Ciudad de Mexico, México. AP. 70228, CP. 04510, México, D.F, Mexico.
Zavala G; Unidad de Microscopia Electrónica, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Mor, Mexico.
Luviano A; Departamento de Genética del Desarrollo y Fisiologia Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Mor, Mexico.
Olvera A; Departamento de Biología Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, 62210, Cuernavaca, Mor, Mexico.
Alagón A; Departamento de Biología Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, 62210, Cuernavaca, Mor, Mexico.
Ramírez OT; Departamento de Biología Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, 62210, Cuernavaca, Mor, Mexico.
Trujillo-Roldán MA; Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Cd. Universitaria, Coyoacán, Ciudad de Mexico, México. AP. 70228, CP. 04510, México, D.F, Mexico. .; Centro de Nanociencias y Nanotecnología, Universidad Nacional Autónoma de México, Km 107 Carretera, 22860, Tijuana-Ensenada, Baja California, Mexico. .
Pokaż więcej
Źródło:
Microbial cell factories [Microb Cell Fact] 2024 Feb 06; Vol. 23 (1), pp. 41. Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:
Journal Article
MeSH Terms:
SARS-CoV-2*
COVID-19*
Animals ; Humans ; Mice ; Adjuvants, Immunologic ; COVID-19 Vaccines ; Escherichia coli ; Administration, Oral ; Antigens, Viral ; Antibodies, Neutralizing ; Peptides ; Antibodies, Viral
Czasopismo naukowe
Tytuł:
Oral administration of DNA alginate nanovaccine induced immune-protection against Helicobacter pylori in Balb/C mice.
Autorzy:
Kaveh-Samani A; Biotechnology Research Center, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.
Dalali S; Biotechnology Research Center, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.
Kaviani F; Biotechnology Research Center, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.
Piri-Gharaghie T; Biotechnology Research Center, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.; Biotechnology Research Center, East Tehran Branch, Islamic Azad University, Tehran, Iran.
Doosti A; Biotechnology Research Center, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran. .
Pokaż więcej
Źródło:
BMC immunology [BMC Immunol] 2024 Feb 03; Vol. 25 (1), pp. 11. Date of Electronic Publication: 2024 Feb 03.
Typ publikacji:
Journal Article
MeSH Terms:
Helicobacter pylori*/genetics
Helicobacter Infections*/prevention & control
Animals ; Mice ; Nanovaccines ; Mice, Inbred BALB C ; Bacterial Vaccines ; DNA ; Administration, Oral ; Antibodies, Bacterial
Czasopismo naukowe
Tytuł:
Evaluation of the efficacy of Simparica Trio in the prevention of the transmission of Babesia canis by infected Dermacentor reticulatus to dogs.
Autorzy:
Borowski S; Zoetis Belgium SA, Veterinary Medicine Research & Development, Mercuriusstraat 20, 1930, Zaventem, Belgium. .
Viljoen A; Clinvet International, Uitzich Road, Bainsvlei, Bloemfontein, 9338, South Africa.
D'Hanis L; Zoetis Belgium SA, Veterinary Medicine Research & Development, Mercuriusstraat 20, 1930, Zaventem, Belgium.
Mahabir S; Zoetis, Veterinary Medicine Research & Development, 333 Portage Street, Kalamazoo, MI, 49007, USA.
Geurden T; Zoetis Belgium SA, Veterinary Medicine Research & Development, Mercuriusstraat 20, 1930, Zaventem, Belgium.
Pokaż więcej
Źródło:
Parasites & vectors [Parasit Vectors] 2024 Feb 02; Vol. 17 (1), pp. 51. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:
Randomized Controlled Trial, Veterinary; Journal Article
MeSH Terms:
Acaricides*/therapeutic use
Babesia*/genetics
Babesiosis*/prevention & control
Dog Diseases*/drug therapy
Dog Diseases*/prevention & control
Animals ; Dogs ; Administration, Oral ; Azetidines ; Dermacentor ; Macrolides ; Pyrantel/therapeutic use ; Spiro Compounds ; Tick Infestations/drug therapy ; Tick Infestations/prevention & control ; Tick Infestations/veterinary
Czasopismo naukowe
Tytuł:
A pilot study investigating plasma pharmacokinetics and tolerance of oral capecitabine in carcinoma-bearing dogs.
Autorzy:
Wetzel S; Previously affiliated with the College of Veterinary Medicine, Washington State University, Pullman, WA, USA. .; Currently associated with SASH (Small Animal Specialist Hospital), North Ryde, NSW, Australia. .
Fidel J; College of Veterinary Medicine, Washington State University, Pullman, WA, USA.
Whittington D; School of Pharmacy, University of Washington, Seattle, WA, USA.
Villarino NF; College of Veterinary Medicine, Washington State University, Pullman, WA, USA.
Pokaż więcej
Źródło:
BMC veterinary research [BMC Vet Res] 2024 Jan 31; Vol. 20 (1), pp. 36. Date of Electronic Publication: 2024 Jan 31.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma*/drug therapy
Carcinoma*/veterinary
Dog Diseases*/etiology
Dogs ; Humans ; Animals ; Capecitabine/therapeutic use ; Pilot Projects ; Deoxycytidine/adverse effects ; Fluorouracil/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Administration, Oral
Czasopismo naukowe
Tytuł:
Disturbance of consciousness caused by dyclonine hydrochloride mucilage: a case report.
Autorzy:
Wang L; Department of Gastroenterology, Sichuan Mianyang 404 Hospital, Mianyang, Sichuan, 621000, China.
Wen QH; Department of Gastroenterology, Sichuan Mianyang 404 Hospital, Mianyang, Sichuan, 621000, China.
Wen LJ; Department of infectious diseases, Sichuan Mianyang 404 Hospital, Mianyang, Sichuan, 621000, China.
Qin JM; Department of Gastroenterology, Sichuan Mianyang 404 Hospital, Mianyang, Sichuan, 621000, China.
Ren CM; Department of Gastroenterology, Sichuan Mianyang 404 Hospital, Mianyang, Sichuan, 621000, China.
Wen LM; Department of Gastroenterology, Sichuan Mianyang 404 Hospital, Mianyang, Sichuan, 621000, China. .
Pokaż więcej
Źródło:
BMC anesthesiology [BMC Anesthesiol] 2024 Jan 22; Vol. 24 (1), pp. 34. Date of Electronic Publication: 2024 Jan 22.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Consciousness*
Brain*
Propiophenones*
Female ; Humans ; Aged ; Administration, Oral ; Anesthesia, Local
Czasopismo naukowe
Tytuł:
Characteristics of patients with schizophrenia switching from oral antipsychotics to once-monthly paliperidone palmitate (PP1M): a systematic review.
Autorzy:
Li Q; Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Centre for Mental Disorders (Peking University Sixth Hospital), Beijing, China.
Li X; Xi'an Janssen Pharmaceutical Ltd, Chaoyang District, Beijing, China.
Ye C; Xi'an Janssen Pharmaceutical Ltd, Chaoyang District, Beijing, China.
Jia M; Xi'an Janssen Pharmaceutical Ltd, Chaoyang District, Beijing, China.
Si T; Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Centre for Mental Disorders (Peking University Sixth Hospital), Beijing, China. .
Pokaż więcej
Źródło:
BMC psychiatry [BMC Psychiatry] 2024 Jan 19; Vol. 24 (1), pp. 57. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:
Systematic Review; Journal Article
MeSH Terms:
Antipsychotic Agents*/therapeutic use
Schizophrenia*/drug therapy
Humans ; Paliperidone Palmitate/therapeutic use ; Administration, Oral ; Treatment Outcome
Czasopismo naukowe
Tytuł:
The residue of salinomycin in the muscles of olive flounder (Paralichthys olivaceus) and black rockfish (Sebastes Schlegeli) after oral administration analyzed by LC-Tandem-MS.
Autorzy:
Lee S; Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Woo WS; Department of Marine Biology & Aquaculture, Institute of Marine Industry, College of Marine Science, Gyeongsang National University, Tongyeong, 53064, Republic of Korea.
Kim J; Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Jin Y; Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Lee JW; College of Pharmacy, Duksung Women's University, Seoul, 01369, Republic of Korea.
Seo JS; Aquatic Disease Control Division, National Fishery Products Quality Management Service, 337 Haeyang-ro, Yeongdo-gu, Busan, 49111, Republic of Korea.
Kwon MG; Aquatic Disease Control Division, National Fishery Products Quality Management Service, 337 Haeyang-ro, Yeongdo-gu, Busan, 49111, Republic of Korea.
Lee JH; Aquatic Disease Control Division, National Fishery Products Quality Management Service, 337 Haeyang-ro, Yeongdo-gu, Busan, 49111, Republic of Korea. .
Park CI; Department of Marine Biology & Aquaculture, Institute of Marine Industry, College of Marine Science, Gyeongsang National University, Tongyeong, 53064, Republic of Korea. .
Shim SH; Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea. sanghee_.
Pokaż więcej
Źródło:
BMC veterinary research [BMC Vet Res] 2024 Jan 12; Vol. 20 (1), pp. 24. Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Flounder*
Fish Diseases*/drug therapy
Fish Diseases*/parasitology
Perciformes*
Polyether Polyketides*
Pyrans*
Humans ; Animals ; Fishes ; Muscles/parasitology ; Administration, Oral
Czasopismo naukowe
Tytuł:
Polymeric nanoparticles (PNPs) for oral delivery of insulin.
Autorzy:
Wang Y; School of Chemistry and Chemical Engineering/State Key Laboratory Incubation Base for Green, Processing of Chemical Engineering, Shihezi University, Shihezi, 832003, China.
Li H; School of Chemistry and Chemical Engineering/State Key Laboratory Incubation Base for Green, Processing of Chemical Engineering, Shihezi University, Shihezi, 832003, China.
Rasool A; Institute of Biochemistry, University of Balochistan, Quetta, 78300, Pakistan. .
Wang H; College of Chemical Engineering and Technology, Tianshui Normal University, Tianshui, 741000, China. .
Manzoor R; Department of Biotechnology and Bioinformatics, Water and Marine Sciences, Lasbella University of Agriculture, Uthal, 90150, Pakistan.
Zhang G; School of Chemistry and Chemical Engineering/State Key Laboratory Incubation Base for Green, Processing of Chemical Engineering, Shihezi University, Shihezi, 832003, China. zhgl_.
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2024 Jan 03; Vol. 22 (1), pp. 1. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Insulin*
Nanoparticles*
Humans ; Drug Delivery Systems/methods ; Quality of Life ; Polymers ; Administration, Oral ; Drug Carriers
Czasopismo naukowe
Tytuł:
Meta-analysis of outcomes following intravenous thrombolysis in patients with ischemic stroke on direct oral anticoagulants.
Autorzy:
Behnoush AH; School of Medicine, Tehran University of Medical Sciences, Poursina St., Keshavarz Blvd, Tehran, 1417613151, Iran.; Cardiovascular Diseases Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Khalaji A; School of Medicine, Tehran University of Medical Sciences, Poursina St., Keshavarz Blvd, Tehran, 1417613151, Iran. .; Cardiovascular Diseases Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran. .
Bahiraie P; School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Gupta R; Department of Cardiology, Lehigh Valley Health Network, Allentown, PA, USA.
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2023 Dec 15; Vol. 23 (1), pp. 440. Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Stroke*/etiology
Ischemic Stroke*/drug therapy
Atrial Fibrillation*/complications
Humans ; Anticoagulants/adverse effects ; Hemorrhage/chemically induced ; Intracranial Hemorrhages/chemically induced ; Intracranial Hemorrhages/epidemiology ; Intracranial Hemorrhages/complications ; Thrombolytic Therapy/adverse effects ; Administration, Oral
Czasopismo naukowe
Tytuł:
Safety, tolerability, pharmacokinetics and effects of diet on AD16, a novel neuroinflammatory inhibitor for Alzheimer's disease: a randomized phase 1 study.
Autorzy:
Peng D; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, 410008, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.; International Science and Technology Innovation Cooperation Base for Early Clinical Trials of Biological Agents in Hunan Province, Changsha, China.
Xu S; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.; Phase I Clinical Research Center, Xiangya Hospital, Central South University, Changsha, China.
Zou T; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, 410008, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
Wang Y; The South China Center for Innovative Pharmaceuticals, Guangzhou, China.
Ouyang W; Xiangya Changde Hospital, Central South University, Changde, China.
Zhang Y; First People's Hospital of Chongqing Liangjiang New Area, Chongqing, China.
Dong C; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, 410008, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.; International Science and Technology Innovation Cooperation Base for Early Clinical Trials of Biological Agents in Hunan Province, Changsha, China.
Li D; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, 410008, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.; Phase I Clinical Research Center, Xiangya Hospital, Central South University, Changsha, China.
Guo J; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, 410008, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
Shen Q; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.; Phase I Clinical Research Center, Xiangya Hospital, Central South University, Changsha, China.
Hu X; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, 410008, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.; Phase I Clinical Research Center, Xiangya Hospital, Central South University, Changsha, China.
Zhou W; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, 410008, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
Li X; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, 410008, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.; Phase I Clinical Research Center, Xiangya Hospital, Central South University, Changsha, China.
Qin Q; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, 410008, China. .; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China. .; International Science and Technology Innovation Cooperation Base for Early Clinical Trials of Biological Agents in Hunan Province, Changsha, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2023 Nov 23; Vol. 21 (1), pp. 459. Date of Electronic Publication: 2023 Nov 23.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease*/drug therapy
Adult ; Humans ; Cross-Over Studies ; Neuroinflammatory Diseases ; Fasting ; Double-Blind Method ; Dose-Response Relationship, Drug ; Area Under Curve ; Administration, Oral
Czasopismo naukowe
Tytuł:
Real-world data emulating randomized controlled trials of non-vitamin K antagonist oral anticoagulants in patients with venous thromboembolism.
Autorzy:
Yoon D; School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.; Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea.
Jeong HE; School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.; Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea.
Park S; School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.; Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK.
You SC; Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea.
Bang SM; Division of Hemato-Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
Shin JY; School of Pharmacy, Sungkyunkwan University, Suwon, South Korea. .; Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea. .; Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, South Korea. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2023 Sep 29; Vol. 21 (1), pp. 375. Date of Electronic Publication: 2023 Sep 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anticoagulants*/adverse effects
Venous Thromboembolism*/drug therapy
Venous Thromboembolism*/diagnosis
Female ; Humans ; Administration, Oral ; Dabigatran/adverse effects ; Randomized Controlled Trials as Topic ; Rivaroxaban/adverse effects ; Male ; Middle Aged ; Aged
Czasopismo naukowe
Tytuł:
Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis.
Autorzy:
Zhou H; Department of Vascular Surgery, The Second Affiliated Hospital of Chongqing Medical University, #76 Linjiang Road, Yuzhong District, Chongqing, 400010, People's Republic of China.
Wu M; Department of Vascular Surgery, The Second Affiliated Hospital of Chongqing Medical University, #76 Linjiang Road, Yuzhong District, Chongqing, 400010, People's Republic of China.
Yu S; Department of General Surgery, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College, Chongqing, 400060, People's Republic of China.
Xia H; Department of Cardiothoracic Surgery, Second Clinical Hospital, Army Medical University, Chongqing, 400000, People's Republic of China.
Yu W; Department of Vascular Surgery, The Second Affiliated Hospital of Chongqing Medical University, #76 Linjiang Road, Yuzhong District, Chongqing, 400010, People's Republic of China.
Huang K; Department of Vascular Surgery, The Second Affiliated Hospital of Chongqing Medical University, #76 Linjiang Road, Yuzhong District, Chongqing, 400010, People's Republic of China.
Chen Y; Department of Vascular Surgery, The Second Affiliated Hospital of Chongqing Medical University, #76 Linjiang Road, Yuzhong District, Chongqing, 400010, People's Republic of China. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2023 Sep 25; Vol. 23 (1), pp. 329. Date of Electronic Publication: 2023 Sep 25.
Typ publikacji:
Journal Article
MeSH Terms:
End Stage Liver Disease*
Venous Thrombosis*/complications
Venous Thrombosis*/drug therapy
Humans ; Rivaroxaban/adverse effects ; Anticoagulants/adverse effects ; Dabigatran/adverse effects ; Portal Vein/pathology ; Retrospective Studies ; Administration, Oral ; Treatment Outcome ; Severity of Illness Index ; Liver Cirrhosis/drug therapy ; Hemorrhage/chemically induced
Czasopismo naukowe
Tytuł:
A multifunctional integrated biomimetic spore nanoplatform for successively overcoming oral biological barriers.
Autorzy:
Song Q; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, People's Republic of China.; Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou, 450001, People's Republic of China.; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou, 450001, People's Republic of China.
Yang J; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, People's Republic of China.; Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou, 450001, People's Republic of China.
Wu X; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, People's Republic of China.; Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou, 450001, People's Republic of China.
Li Y; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, People's Republic of China.; Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou, 450001, People's Republic of China.
Zhao H; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, People's Republic of China.; Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou, 450001, People's Republic of China.; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou, 450001, People's Republic of China.
Feng Q; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, People's Republic of China.; Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou, 450001, People's Republic of China.; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou, 450001, People's Republic of China.
Zhang Z; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, People's Republic of China. .; Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou, 450001, People's Republic of China. .; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou, 450001, People's Republic of China. .
Zhang Y; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, People's Republic of China. zhang_.; Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou, 450001, People's Republic of China. zhang_.; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou, 450001, People's Republic of China. zhang_.
Wang L; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, People's Republic of China. .; Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou, 450001, People's Republic of China. .; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou, 450001, People's Republic of China. .
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2023 Aug 29; Vol. 21 (1), pp. 302. Date of Electronic Publication: 2023 Aug 29.
Typ publikacji:
Journal Article
MeSH Terms:
Biomimetics*
Capsid Proteins*
Spores ; Gastrointestinal Tract ; Administration, Oral
Czasopismo naukowe
Tytuł:
Cracking the intestinal lymphatic system window utilizing oral delivery vehicles for precise therapy.
Autorzy:
Miao YB; Department of Haematology, School of Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610000, China. .; Sichuan Provincial Key Laboratory for Human Disease Gene Study, Center for Medical Genetics, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610072, China. .
Xu T; Department of Haematology, School of Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610000, China.
Gong Y; School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, 610031, People's Republic of China.
Chen A; School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, 610031, People's Republic of China.
Zou L; School of Food and Biological Engineering, Chengdu University, Chengdu, Sichuan, 610106, China.
Jiang T; Department of Haematology, School of Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610000, China. .
Shi Y; Sichuan Provincial Key Laboratory for Human Disease Gene Study, Center for Medical Genetics, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610072, China. .; Natural Products Research Center, Institute of Chengdu Biology, Sichuan Translational Medicine Hospital, Chinese Academy of Sciences, Chengdu, Sichuan, 610072, China. .; Research Unit for Blindness Prevention of Chinese Academy of Medical Sciences (2019RU026), Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, Sichuan, 610072, China. .
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2023 Aug 10; Vol. 21 (1), pp. 263. Date of Electronic Publication: 2023 Aug 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lymphatic System*
Gastrointestinal Tract*
Humans ; Pharmaceutical Preparations ; Drug Delivery Systems ; Biological Availability ; Administration, Oral
Czasopismo naukowe
Tytuł:
Clinical efficacy of duloxetine in the treatment of axial symptoms after posterior cervical spine surgery: a retrospective study.
Autorzy:
Liu J; Department of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Yang X; Department of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, China.; Department of Burn and Plastic Surgery, People's Hospital of Chongqing Hechuan, Chongqing, China.
Jing W; Department of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, China.; Department of Orthopaedics, Tianjin First Central Hospital, Tianjin, China.
Guo X; Department of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Wang R; Department of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Zhou J; Department of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, China. .; Tianjin Key Laboratory of Spine and Spinal Cord, Tianjin Medical University General Hospital, Tianjin, China. .
Xue Y; Department of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, China. .; Tianjin Key Laboratory of Spine and Spinal Cord, Tianjin Medical University General Hospital, Tianjin, China. .
Pokaż więcej
Źródło:
Journal of orthopaedic surgery and research [J Orthop Surg Res] 2023 Jul 12; Vol. 18 (1), pp. 496. Date of Electronic Publication: 2023 Jul 12.
Typ publikacji:
Journal Article
MeSH Terms:
Cervical Vertebrae*/surgery
Humans ; Retrospective Studies ; Duloxetine Hydrochloride/therapeutic use ; Treatment Outcome ; Administration, Oral
Czasopismo naukowe
Tytuł:
Extracorporeal hemoadsorption therapy as a potential therapeutic option for rapid removal of Apixaban in high risk-surgical patients: a case report.
Autorzy:
Dalmastri V; Nephrology Dialysis and Renal Transplant Unit IRCCS St, Orsola University Hospital, Bologna, Italy. .
Angelini A; Nephrology Dialysis and Renal Transplant Unit IRCCS St, Orsola University Hospital, Bologna, Italy.
Minerva V; Nephrology Dialysis and Renal Transplant Unit IRCCS St, Orsola University Hospital, Bologna, Italy.
Ballarini M; Dialysis Unit, Maggiore General Hospital, National Public Health System, Largo Nigrisoli, 2, 40133, Bologna, BO, Italy.
Grammatico F; Nephrology Dialysis and Renal Transplant Unit IRCCS St, Orsola University Hospital, Bologna, Italy.
Todeschini P; Nephrology Dialysis and Renal Transplant Unit IRCCS St, Orsola University Hospital, Bologna, Italy.
Pizzini AM; Department of Medicine, Maggiore General Hospital, AUSL, Bologna, Italy.
Silingardi M; Department of Medicine, Maggiore General Hospital, AUSL, Bologna, Italy.
La Manna G; Nephrology Dialysis and Renal Transplant Unit IRCCS St, Orsola University Hospital, Bologna, Italy.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2023 Jul 07; Vol. 17 (1), pp. 283. Date of Electronic Publication: 2023 Jul 07.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Atrial Fibrillation*/therapy
Atrial Fibrillation*/complications
Acute Kidney Injury*/therapy
Acute Kidney Injury*/chemically induced
Male ; Humans ; Aged, 80 and over ; Anticoagulants ; Dabigatran/adverse effects ; Administration, Oral ; Antidotes/therapeutic use ; Hemorrhage/chemically induced ; Pyridones/therapeutic use ; Pyridones/adverse effects
Czasopismo naukowe
Tytuł:
The effect of chronic endometritis and treatment on patients with unexplained infertility.
Autorzy:
Gu J; Reproductive Medical Center of Xuzhou Central Hospital, 221000, Xuzhou, China.
Sun Q; Reproductive Medical Center of Xuzhou Central Hospital, 221000, Xuzhou, China. .
Qi Y; Reproductive Medical Center of Xuzhou Central Hospital, 221000, Xuzhou, China.
Hu F; Reproductive Medical Center of Xuzhou Central Hospital, 221000, Xuzhou, China.
Cao Y; Reproductive Medical Center of Xuzhou Central Hospital, 221000, Xuzhou, China.
Pokaż więcej
Źródło:
BMC women's health [BMC Womens Health] 2023 Jun 30; Vol. 23 (1), pp. 345. Date of Electronic Publication: 2023 Jun 30.
Typ publikacji:
Journal Article
MeSH Terms:
Endometritis*/complications
Endometritis*/drug therapy
Endometritis*/epidemiology
Abortion, Spontaneous*
Infertility*
Female ; Infant ; Humans ; Pregnancy ; Administration, Oral ; Chronic Disease
Czasopismo naukowe
Tytuł:
Oral administration of bromelain and acetylcysteine in pseudomyxoma peritonei (PMP) caused by low-grade appendiceal mucinous neoplasm (LAMN): a case report.
Autorzy:
Geisel D; Department of Radiology, Charité, Universitätsmedizin Berlin, Campus Virchow-Klinikum, Klinik Für Radiologie, Augustenburger Platz 1, 13353, Berlin, Germany. .
Langen U; Department of Radiology, Charité, Universitätsmedizin Berlin, Campus Virchow-Klinikum, Klinik Für Radiologie, Augustenburger Platz 1, 13353, Berlin, Germany.
Rüdiger T; Department of Radiology, Charité, Universitätsmedizin Berlin, Campus Virchow-Klinikum, Klinik Für Radiologie, Augustenburger Platz 1, 13353, Berlin, Germany.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2023 Jun 29; Vol. 17 (1), pp. 297. Date of Electronic Publication: 2023 Jun 29.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Pseudomyxoma Peritonei*/drug therapy
Appendiceal Neoplasms*/drug therapy
Peritoneal Neoplasms*/drug therapy
Male ; Humans ; Middle Aged ; Administration, Oral
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies